NCT07385144 A Study of a Dietary Supplement on Serum Biomarkers in Children
| NCT ID | NCT07385144 |
| Status | Recruiting |
| Phase | — |
| Sponsor | SF Research Institute, Inc. |
| Condition | Nutritional Status |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-01-30 |
| Primary Completion | 2026-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-01-30 with a primary completion date of 2026-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a pilot clinical study designed to evaluate the effects of a dietary supplement on selected blood-based nutritional biomarkers in healthy children aged 4 to 15 years. Approximately 24 children will be screened and enrolled to account for potential dropouts, with a target of 20 participants completing the study. Eligible participants will attend a screening and baseline visit, followed by daily intake of the study supplement for 4 weeks. After the supplementation period, participants will return to the clinic for an end-of-study visit. Blood samples will be collected at baseline and after 4 weeks to measure nutritional biomarkers, including vitamin D, vitamin B12, folate, omega-3 fatty acids, and standard blood count parameters. Additional assessments include height, weight, body mass index (BMI), and a socioeconomic questionnaire. Throughout the study, participants or their caregivers will record daily supplement intake, any medications taken, and any adverse events in a study diary. The results of this pilot study will provide preliminary data on the effects of the dietary supplement on serum biomarkers in children.
Eligibility Criteria
Inclusion Criteria: * Healthy Male and Females aged 4 - 15 years * NORMAL BMI /growth (per CDC growth tables) Between 5th - 85th percentile. * Able to read, understand, and complete the study questionnaire and records. * Able to understand the study procedures. * Able to comply with all study requirements. * Written informed consent/Assent to participate in the study. * Agrees to maintain current lifestyle habits (diet, physical activity, medications, and sleep) as much as possible throughout the study and avoid taking new supplements * Willingness to actively participate in the study and to come to the scheduled visits. Exclusion Criteria: * Immune insufficiency * Use of systemic corticosteroids or immunosuppressant drugs. * Any diseases or medications that might directly interfere in the study or put the subject's health under risk. * Currently taking any prescription medications or any dietary supplements including multivitamins * Employees of the institute or the brand owner or the manufacturers of the product * Cardiovascular-, chronic liver-, thyroid or kidney diseases; a history of cancer; a disease or condition that could influence the participants' ability to follow the study protocol,
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07385144 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 15 Years, studying Nutritional Status. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07385144 currently recruiting?
Yes, NCT07385144 is actively recruiting participants. Contact the research team at jademola@sfinstitute.com for enrollment information.
Where is the NCT07385144 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT07385144 clinical trial?
NCT07385144 is sponsored by SF Research Institute, Inc.. The trial plans to enroll 30 participants.